Search

Indoco Remedies

Sector: Healthcare | Industry: Drugs & Pharma
R 151.60 7.85  | 5.46% -20.23% 122.77 1,394.70
NSE Price: Oct 18, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 15:59 151.60 7.85 5.46% 141.00 143.75 63,835 141.00 - 154.35
BSE Oct 18, 2019 151.35 7.00 4.85% 145.00 144.35 15,482 144.30 - 154.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 59,668 P/B: 2.10 NSE Code: INDOCO
52-Week Range: R 132.45 - 238.70 Dividend Yield: 0.20% BSE Code: 532612
TTM EPS: R 1.23 Book Value: R 71.98 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Indoco Remedies -29.99 -3.19 -5.28 -20.18 -21.21 -11.47 16.57
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of NSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -7.05 -1.33 5.74
Net Profit -107.06 -132.85 -154.94
EPS -107.06 -132.85 -154.95
Book Value -2.13 4.64 7.64
Average
Operating Margin 8.55 12.29 14.69
Net Margin -0.30 3.58 5.70
Return on Networth -0.43 6.11 10.05
Return on Investment 1.17 6.86 11.59
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - 16.01 -
Operating Profit - 96.67 -
Net Profit - 115.18 -
EPS - 115.18 -
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Indoco Remedies 1,394.70 1,002.88 11.36 1.13 -0.43 2.10 122.77
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 05, 2019 MEGH MILIND PANANDIKAR  Buy Market 11,200 157.35 17.62
Jul 24, 2018 Reliance Capital Trustee Co Ltd  Buy Market 370,431 188.90 699.74
Jul 02, 2018 DSP BlackRock Trustee Co Ltd  Sell Market 550,000 177.10 974.05
Jul 02, 2018 DSP BlackRock Trustee Company Pvt Ltd  Sell Market 550,000 177.10 974.05
Mar 05, 2018 DSP BlackRock Trustee Co Pvt Ltd  Buy Market 71,308 255.15 181.94
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Nippon India Mutual Fund 5.995 6.497 6.494 6.494 6.494
HDFC Mutual Fund 2.833 2.245 2.162 2.133 1.838
IDFC Mutual Fund 2.107 2.086 2.054 1.985 1.967
ICICI Prudential Mutual Fund 1.727 1.694 1.621 1.044 0.959
DSP Mutual Fund 0.696 0.617 0.421 0.302 -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Indoco Remedies Ltd.

Address: Indoco House, 166 C S T Road, Kalina , Santacruz (East), Mumbai, Maharashtra - 400098 | Phone: 022-26541851-55 | Fax: 022-26520787

Website: www.indoco.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
3.06
Piotroski F-Score
3
Modified C-Score
2
5-Years Price to Earnings
122.77
5-Years Price to Book
2.10
Earnings Yield
EBIT / Enterprise value
1.36%
PEG
Price / Earnings to growth ratio
-4.06
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59